| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5886184 | ORGANON | Finasteride processes |
Nov, 2012
(11 years ago) | |
| US5942519 | ORGANON | Prevention of precipitated acute urinary retention |
Oct, 2018
(5 years ago) | |
Proscar is owned by Organon.
Proscar contains Finasteride.
Proscar has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Proscar are:
- US5886184
- US5942519
Proscar was authorised for market use on 19 June, 1992.
Proscar is available in tablet;oral dosage forms.
Proscar can be used as treating precipitated acute urinary retention with finasteride.
The generics of Proscar are possible to be released after 23 October, 2018.
Drugs and Companies using FINASTERIDE ingredient
Market Authorisation Date: 19 June, 1992
Treatment: Treating precipitated acute urinary retention with finasteride
Dosage: TABLET;ORAL
How can I launch a generic of PROSCAR before it's drug patent expiration?
More Information on Dosage
PROSCAR family patents
